{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:26:42Z","timestamp":1791322002270,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.biologicals.2006.02.006","type":"journal-article","created":{"date-parts":[[2006,5,9]],"date-time":"2006-05-09T13:20:57Z","timestamp":1147180857000},"page":"167-170","source":"Crossref","is-referenced-by-count":6,"title":["Gaps in scientific knowledge for the post eradication world"],"prefix":"10.1016","volume":"34","author":[{"given":"Philip","family":"Minor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2006.02.006_bib1","first-page":"925","article-title":"Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus","volume":"40","author":"WHO consultative group","year":"1969","journal-title":"Bull World Health Organ"},{"issue":"5879","key":"10.1016\/j.biologicals.2006.02.006_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/299109a0","article-title":"Poliomyelitis\u2013epidemiology, molecular biology and immunology","volume":"299","author":"Minor","year":"1982","journal-title":"Nature"},{"issue":"Pt 2","key":"10.1016\/j.biologicals.2006.02.006_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1099\/0022-1317-61-2-167","article-title":"Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping","volume":"61","author":"Minor","year":"1982","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.biologicals.2006.02.006_bib4","first-page":"239","article-title":"WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains","volume":"64","author":"Ferguson","year":"1986","journal-title":"Bull World Health Organ"},{"issue":"Suppl. 2","key":"10.1016\/j.biologicals.2006.02.006_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/clinids\/6.Supplement_2.S335","article-title":"Inactivated poliovirus vaccine: current production methods and new developments","volume":"6","author":"van Wezel","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.biologicals.2006.02.006_bib6","first-page":"16","article-title":"The Cutter incident: poliomyelitis following formaldehyde inactivated poliovirus vaccination in the United States during the spring of 1955","volume":"78","author":"Nathanson","year":"1963","journal-title":"Am J Hyg"},{"key":"10.1016\/j.biologicals.2006.02.006_bib7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.123.3209.1151","article-title":"Pathogenesis of poliomyelitis: reappraisal in the light of new data.","volume":"123","author":"Sabin","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2006.02.006_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1045-1056(05)80003-X","article-title":"Genetic characterisation of Sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract","volume":"20","author":"Contreras","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2006.02.006_bib9","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1099\/0022-1317-73-12-3065","article-title":"The molecular biology of poliovaccines","volume":"73","author":"Minor","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2006.02.006_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1099\/0022-1317-67-4-693","article-title":"Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccine","volume":"67","author":"Minor","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2006.02.006_bib11","doi-asserted-by":"crossref","unstructured":"Fine PE, Carneiro IA. Transmissibility and persistence of oral poliovaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol 1999;150:1001\u201321.","DOI":"10.1093\/oxfordjournals.aje.a009924"},{"key":"10.1016\/j.biologicals.2006.02.006_bib12","first-page":"163","article-title":"Progress with inactivated poliovirus vaccines derived from the Sabin strains","volume":"105","author":"Doi","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.biologicals.2006.02.006_bib13","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/424524","article-title":"Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy","volume":"190","author":"Dragunsky","year":"2004","journal-title":"J Inf Dis"},{"issue":"Pt 4","key":"10.1016\/j.biologicals.2006.02.006_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1099\/0022-1317-74-4-685","article-title":"Antigenic structure of poliovirus in inactivated vaccines","volume":"74","author":"Ferguson","year":"1993","journal-title":"J GenVirol"},{"issue":"Pt 7","key":"10.1016\/j.biologicals.2006.02.006_bib15","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/vir.0.19088-0","article-title":"Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains","volume":"84","author":"Martin","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2006.02.006_bib16","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1987.03390100073029","article-title":"Vaccine associated paralytic poliomyelitis in the United States: 1973 through 1984","volume":"257","author":"Nkowane","year":"1987","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.biologicals.2006.02.006_bib17","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0264-410X(97)85582-X","article-title":"Immunization of pregnant women could protect babies from vaccine associated poliomyelitis","volume":"15","author":"Minor","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2006.02.006_bib18","first-page":"75","article-title":"Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies","volume":"105","author":"Minor","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.biologicals.2006.02.006_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/pgmj.67.785.301","article-title":"Prolonged faecal excretion of poliovirus in a nurse wih common variable hypogammaglobulinaemia","volume":"67","author":"Misbah","year":"1991","journal-title":"Post grad Med J"},{"key":"10.1016\/j.biologicals.2006.02.006_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00917895","article-title":"Inadequacy of mucosal IgM anti-bodies in selective IgA deficiency: excretion of attenuated polioviruses is prolonged","volume":"8","author":"Savilahti","year":"1999","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.biologicals.2006.02.006_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jmv.20250","article-title":"Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains","volume":"75","author":"Minor","year":"2005","journal-title":"J Med Virol"},{"issue":"9420","key":"10.1016\/j.biologicals.2006.02.006_bib22","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(04)16150-3","article-title":"Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man","volume":"363","author":"MacLennan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2006.02.006_bib23","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biologicals.2006.02.006_bib24","first-page":"72","article-title":"Hypogammaglobulinaemia in the United Kingdom, VII. The role of humoral antibodies in protection against and recovery from bacterial and viral infections in hypogammaglobulinaemia.","volume":"310","author":"MacCallum","year":"1971","journal-title":"Spec Rep Ser Med Res Counc"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105606000327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105606000327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T14:55:45Z","timestamp":1555599345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105606000327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1045105606000327"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2006.02.006","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}